Sunshine Biopharma Inc (SBFM.PK) Quote| Reuters.com
Edition:
United States

Sunshine Biopharma Inc (SBFM.PK)

SBFM.PK on OTC Markets Group

0.01USD
1 Jul 2016
Change (% chg)

$0.00 (+24.59%)
Prev Close
$0.01
Open
$0.01
Day's High
$0.01
Day's Low
$0.00
Volume
2,110,780
Avg. Vol
1,647,471
52-wk High
$0.04
52-wk Low
$0.00

SBFM.PK

Chart for SBFM.PK

About

Sunshine Biopharma, Inc. is a pharmaceutical company. The Company focuses on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead compound is Adva-27a, which is a GEM-difluorinated C-glycoside derivative of Podophyllotoxin, targeted for various forms of cancer.... (more)
No analyst recommendations are available for SBFM.PK.

Overall

Beta: -0.03
Market Cap(Mil.): $1.64
Shares Outstanding(Mil.): 268.88
Dividend: --
Yield (%): --

Financials

  SBFM.PK Industry Sector
P/E (TTM): -- 42.29 36.15
EPS (TTM): -0.01 -- --
ROI: -- -6.23 14.31
ROE: -- -5.61 15.51

Competitors

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00
Provider : GlobalData
$300.00
Provider : GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.